Health policy: Strategies to optimize expedited investigational new drug safety reports

Apostolia M. Tsimberidou

doi:10.1038/nrclinonc.2016.42

Health policy: Strategies to optimize expedited investigational new drug safety reports

Apostolia M. Tsimberidou

Investigational Cancer Therapeutics

Research output: Contribution to journal › Short survey › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	207-208
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	13
Issue number	4
DOIs	https://doi.org/10.1038/nrclinonc.2016.42
State	Published - Apr 1 2016

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/nrclinonc.2016.42

Cite this

@article{0dabbaa8412f4e3d82f67c0943feafbf,

title = "Health policy: Strategies to optimize expedited investigational new drug safety reports",

author = "Tsimberidou, {Apostolia M.}",

year = "2016",

month = apr,

day = "1",

doi = "10.1038/nrclinonc.2016.42",

language = "English (US)",

volume = "13",

pages = "207--208",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Health policy

T2 - Strategies to optimize expedited investigational new drug safety reports

AU - Tsimberidou, Apostolia M.

PY - 2016/4/1

Y1 - 2016/4/1

UR - http://www.scopus.com/inward/record.url?scp=84961753015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961753015&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2016.42

DO - 10.1038/nrclinonc.2016.42

M3 - Short survey

C2 - 26997460

AN - SCOPUS:84961753015

SN - 1759-4774

VL - 13

SP - 207

EP - 208

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 4

ER -

Health policy: Strategies to optimize expedited investigational new drug safety reports

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this